IP Library Granted Patent US 7,879,562
Granted Patent B2
US 7,879,562 · App. 12/460,255 · Granted Feb 1, 2011

Methods of diagnosing endometriosis in human subjects using the ME-5 polypeptide

Assignee: Siemens Healthcare Diagnostics Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,562
App. No.
12/460,255
Granted
Feb 1, 2011
Kind
B2
Abstract

A method for diagnosing endometriosis in a human subject comprising the steps of detecting a test amount of an antibody that specifically binds to ME-5 (SEQ ID NO:3) polypeptide or a peptide comprising an epitope of ME-5 in a sample from the subject; and comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.

Claims (9)

1. A method for diagnosing endometriosis in a human subject comprising the steps of:

(a) detecting a test amount of an antibody that specifically binds to SEQ ID NO:3 polypeptide or a truncated peptide comprising an epitope of SEQ ID NO: 3, in a sample from the subject; and

(b) comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.

2. The method of claim 1 , wherein the sample comprises blood serum.

3. The method of claim 1 or 2 , wherein the step of detecting comprises capturing the antibody from the sample with an immobilized peptide where said peptide is SEQ ID NO: 3 or a peptide comprising an epitope of SEQ ID NO: 3 and detecting captured antibody.

4. The method of claim 1 wherein said polypeptide has amino acid sequences identical to SEQ ID NO:3.

5. The method of claim 1 wherein said peptide is a truncated peptide comprising an epitope of SEQ ID NO: 3.

6. The method of claim 1 wherein said SEQ ID NO: 3 polypeptide is produced by recombinant means.

7. The method of claim 1 wherein said truncated peptide of SEQ ID NO: 3 is produced by recombinant means.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2010
From: SHAMI, A SAID EL; CAMPBELL, BRUCE; SUSTARSIC, DENNIS; SAHAKIAN, NIVER
To: DIAGNOSTIC PRODUCTS CORPORATION
Reel/Frame 025347/0926 →
CHANGE OF NAME Recorded Nov 11, 2010
From: DIAGNOSTICS PRODUCTS CORPORATION
To: SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
Reel/Frame 025347/0949 →
CHANGE OF NAME Recorded Nov 11, 2010
From: SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 025348/0012 →
Continuity (3)
Division 1159387400 · Nov 6, 2006
Division 1088754000 · Jul 7, 2004
Related Publication 20100062453A1 · Mar 11, 2010